Alzheimer’s is a condition without a cure that leads to detrimental results for the affected person. But, new studies suggest that a nutrient drink sold at supermarkets and health food stores can slow down the signs and symptoms of this condition. These are bold claims, and one that shows you cannot always believe the things that you read on the internet. New research from various organizations prove their is no accuracy to back these claims against this medical condition.
- Souvenaid, a nutritional supplement beverage that contains the active ingredient Fortasyn Connect, is marketed in the U.K. specifically for the management of early Alzheimer’s.
- According to a recent trial published in The Lancet Neurology, Souvenaid may help to slow down the early stages of Alzheimer’s disease.
- While the findings on Souvenaid are interesting, the lack of scientific evidence in some of the study’s endpoints means more research is needed before reaching a definitive conclusion.
“It’s a bold claim: the brain regrows vital neuronal connections after a person in the early stages of Alzheimer’s disease sips a daily nutrient drink. Cognitive decline slows down. But that’s not what the latest study found.”